NCT02957305View on ClinicalTrials.gov

Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage

PHASE4CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

December 21, 2016

Primary Completion Date

October 19, 2019

Study Completion Date

June 30, 2020

Conditions
Miscarriage in First Trimester
Interventions
DRUG

Misoprostol 400mcg Tab

400µg of misoprostol (2 tablets)

DRUG

Misoprostol 200mcg Tab

200µg of misoprostol (1 tablet)

Trial Locations (1)

90035-903

HCPA, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT02957305 - Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage | Biotech Hunter | Biotech Hunter